Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD

Summary

The purpose of this study is to investigate the effect of a 9-month treatment of tiotropium (SPIRIVA®) 18 mcg once daily on Health Related Quality of Life and lung function in patients with a Chronic Obstructive Pulmonary Disease.

Timeline

Start

2002-04

Primary completion

2004-04

Completion

2004-04

Drugs

Indications